---
name: Capitol Biologics
slug: capitolbiologics
site: cdmo
website_domain: capitolbiologics.com
summary: Early-phase biologics CDMO offering cell line development, process development, GMP drug substance manufacturing, and analytical and QC testing for monoclonal antibodies and proteins.
tagline: From Concept to Clinic, Seamlessly
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-27T07:04:53.626Z
services_count: 9
modalities_count: 2
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Capitol Biologics

From Concept to Clinic, Seamlessly

Listed on cdmo.directory.

## Summary

Early-phase biologics CDMO offering cell line development, process development, GMP drug substance manufacturing, and analytical and QC testing for monoclonal antibodies and proteins.

## Services

- Cell-Line Development
- Process Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Formulation Development
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing

## Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

## Long description

## Overview

Capitol Biologics describes itself as a full-service CDMO supporting the R&D and early-phase clinical trial manufacturing needs of emerging biotech firms. The company focuses on quality-driven biologic, protein, and monoclonal antibody drug development, from cell line development through GMP manufacturing.

## Services

- **Cell line development**, including stable cell line production and cell line workflow.
- **Process development**, including process development and scale-up, bioprocess development, and a bioprocessing platform.
- **Analytical development and product characterization**, including comprehensive analytical services, compendial methods, qualified analytical methods, characterization methods, and cell-based assays.
- **GMP manufacturing**, including a manufacturing platform, clinical drug substance manufacturing, and process validation.
- **Formulation and drug product development**, as referenced in the Cell Line, Process & Product Development service area.
- **QC testing and quality assurance**, including release and stability testing, quality control, and a quality management system.

## Differentiation

The company cites a proven track record in biologics development and manufacturing, single-use technology and scalable platforms, and deployment of next-generation continuous manufacturing processes. Its stated approach is phase-appropriate and fit-for-purpose, with an emphasis on efficient delivery.

## Background

Capitol Biologics is described as a new venture from BioFactura, a company founded in 2004 that focuses on small-scale biologics development and manufacturing.

## Related companies

- [Enzene Biosciences](/companies/enzene) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/enzene)
- [Creative Biolabs](/companies/creativebiolabs) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/creativebiolabs)
- [KBI Biopharma, Inc.](/companies/kbibiopharma) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/kbibiopharma)
- [Bionova Scientific](/companies/bionova-scientific) (Cell-Line Development, CMC Analytical Development) — [Compare](/compare/bionova-scientific/capitolbiologics)
- [WuXi Biologics](/companies/wuxibiologics) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/wuxibiologics)
- [Wheeler Bio](/companies/wheeler-bio) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/wheeler-bio)
- [WuXi Vaccines](/companies/wuxivaccines) (Cell-Line Development, Process Development) — [Compare](/compare/capitolbiologics/wuxivaccines)
- [Abzena](/companies/abzena) (Cell-Line Development, Process Development) — [Compare](/compare/abzena/capitolbiologics)

_Profile last updated: 2026-10-27T07:04:53.626Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.